Infinity Discovery, Inc.
12Patents
11Active
12Granted
48Portfolio score
Filing activity: Aug 26, 2005 → May 15, 2012 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7230004B2 | Cyclopamine analogues and methods of use thereof | Human Necessities | 55 | Expired |
| US7875628B2 | Cyclopamine analogues and methods of use thereof | Human Necessities | 30 | Active |
| US7648994B2 | Heterocyclic cyclopamine analogs and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US7994191B2 | Heterocyclic cyclopamine analogs and methods of use thereof | Chemistry; Metallurgy | 25 | Active |
| US7964590B2 | Cyclopamine lactam analogs and methods of use thereof | Chemistry; Metallurgy | 25 | Active |
| US8426436B2 | Heterocyclic cyclopamine analogs and methods of use thereof | Chemistry; Metallurgy | 19 | Active |
| US8293760B2 | Cyclopamine lactam analogs and methods of use thereof | Chemistry; Metallurgy | 19 | Active |
| US8431566B2 | Cyclopamine lactam analogs and methods of use thereof | Chemistry; Metallurgy | 19 | Active |
| US7928244B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | Chemistry; Metallurgy | 0 | Active |
| US8609706B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | Chemistry; Metallurgy | 0 | Active |
| US8357676B2 | Ansamycin formulations and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US8304428B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.